Sublingual alternative to shots recommended for pediatric allergies; Recipharm, Synthonics team up to deliver pharma compounds;

> Under-the-tongue oral "drops" appear to offer a viable alternative to shots as a treatment for pediatric allergy patients. Item

> Recipharm Pharmaceutical Development and Synthonics have teamed up to allow the Swedish manufacturer Recipharm to use U.S. company Synthonics' metal coordination chemistry to deliver their compounds. More

> A new gel made from a substance found in the fruit and leaves of the papaya tree delivers a powerful treatment that dissolves tooth decay, a gentler alternative than a dentist's drill. Story

> MagForce won a European patent for its nanoparticle-drug conjugate NanoTherm, which can be heated inside a tumor to release the drug in high concentration therein. The platform has regulatory approval in 27 European countries. News

> Agile Therapeutics announced positive results in two Phase III studies of the company's investigational, once-weekly low-dose contraceptive patch containing ethinyl estradiol and levonorgestrel. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.